Reducing barriers to access provincial COVID-19 vaccination data in Canada

Roadblocks to accessing data on vaccine effectiveness from provincial health ministries impede researchers' ability to inform a national pandemic response and maintain public trust, according to an analysis in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.211712.

Despite recommendations after the SARS outbreak in 2003 to fast-track access to administrative health data to guide pandemic responses, timely access to important data is limited and can limit research abilities.

Robust COVID-19 clinical data sets, with linkages to patient-level administrative data on vaccination, could be leveraged as clinical trial platforms to prospectively evaluate the safety and effectiveness of vaccines and novel COVID-19 therapies. Without linkage to provincially held, patient-level vaccination data, the utility of carefully collected national COVID-19 clinical data sets is substantially constrained."

Dr. Andrew McRae, University of Calgary's Cumming School of Medicine, and coauthors

In this analysis, authors highlight how health ministries can release data for research while also protecting patients' privacy. Establishing partnerships between provincial data groups and Health Data Research Network to link data, enable timely data transfer and support research into vaccine effectiveness would be a key step.

"The absence of a coordinated, pan-Canadian, secure research environment for interprovincial data linkage and analysis has been highlighted as a shortcoming in Canadian research infrastructure that has limited the timeliness of Canadian research, both before and during the pandemic," the authors write.

Provincial health ministries hold COVID-19 vaccination data, but have been reluctant to share it with researchers, limiting researchers' ability to conduct Canadian vaccine research.

"Making administrative data available to independent researchers presents an important opportunity to validate the effectiveness data for vaccines and build public trust in Canada's public health and vaccination strategy."

Source:
Journal reference:

McRae, A.D., et al. (2022) Reducing barriers to accessing administrative data on SARS-CoV-2 vaccination for research. Canadian Medical Association Journal. doi.org/10.1503/cmaj.211712.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Natural immunity to SARS-CoV-2 weakened significantly after Omicron’s emergence